TransMedics (TMDX) Accumulated Expenses (2018 - 2026)

TransMedics' Accumulated Expenses history runs 9 years deep, the most recent figure standing at $19.9 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 43.41% year-over-year to $19.9 million; the TTM figure through Mar 2026 stood at $19.9 million (up 43.41% YoY), while the FY2025 annual figure was $28.4 million, down 37.01% from the prior year.
• Accumulated Expenses was $19.9 million for Q1 2026 at TransMedics, down from $28.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $56.0 million in Q3 2025 to a low of $9.8 million in Q4 2022.
• Historically, Accumulated Expenses has averaged $26.2 million across 5 years, with a median of $20.2 million in 2024.
• Biggest YoY gain for Accumulated Expenses was 373.32% in 2022; the steepest drop was 39.94% in 2022.
• A 5-year view of Accumulated Expenses shows it stood at $9.8 million in 2022, then soared by 289.53% to $38.2 million in 2023, then advanced by 18.13% to $45.2 million in 2024, then tumbled by 37.01% to $28.4 million in 2025, then sank by 30.19% to $19.9 million in 2026.
• The last three Accumulated Expenses figures came in at $19.9 million (Q1 2026), $28.4 million (Q4 2025), and $56.0 million (Q3 2025), per Business Quant data.